Logo image of CNTM

CONNECTM TECHNOLOGY SOLUTION (CNTM) Stock Fundamental Analysis

NASDAQ:CNTM - Nasdaq - US2079441091 - Common Stock - Currency: USD

1.17  +0.03 (+2.63%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CNTM. CNTM was compared to 93 industry peers in the Electrical Equipment industry. Both the profitability and financial health of CNTM have multiple concerns. CNTM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CNTM has reported negative net income.
In the past year CNTM has reported a negative cash flow from operations.
CNTM Yearly Net Income VS EBIT VS OCF VS FCFCNTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -5M -10M

1.2 Ratios

The Return On Assets of CNTM (-21.73%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -44.61%, CNTM is in line with its industry, outperforming 51.09% of the companies in the same industry.
Industry RankSector Rank
ROA -21.73%
ROE -44.61%
ROIC N/A
ROA(3y)-9.67%
ROA(5y)N/A
ROE(3y)-78.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNTM Yearly ROA, ROE, ROICCNTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CNTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNTM Yearly Profit, Operating, Gross MarginsCNTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, CNTM has about the same amount of shares outstanding.
The debt/assets ratio for CNTM is higher compared to a year ago.
CNTM Yearly Shares OutstandingCNTM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 500K 1M 1.5M 2M
CNTM Yearly Total Debt VS Total AssetsCNTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.66, we must say that CNTM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.66, CNTM is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
CNTM has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CNTM (0.04) is better than 68.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -0.66
ROIC/WACCN/A
WACCN/A
CNTM Yearly LT Debt VS Equity VS FCFCNTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.02 indicates that CNTM may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.02, CNTM is doing worse than 96.74% of the companies in the same industry.
A Quick Ratio of 0.02 indicates that CNTM may have some problems paying its short term obligations.
CNTM has a worse Quick ratio (0.02) than 96.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
CNTM Yearly Current Assets VS Current LiabilitesCNTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CNTM have decreased strongly by -92.14% in the last year.
EPS 1Y (TTM)-92.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNTM Yearly Revenue VS EstimatesCNTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
CNTM Yearly EPS VS EstimatesCNTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CNTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTM Price Earnings VS Forward Price EarningsCNTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNTM Per share dataCNTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CNTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONNECTM TECHNOLOGY SOLUTION

NASDAQ:CNTM (2/7/2025, 8:20:52 PM)

1.17

+0.03 (+2.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners20.98%
Inst Owner Change0%
Ins Owners6%
Ins Owner Change10.91%
Market Cap24.86M
AnalystsN/A
Price TargetN/A
Short Float %1.64%
Short Ratio1.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 0.64
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS1.84
TBVpS1.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.73%
ROE -44.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.67%
ROA(5y)N/A
ROE(3y)-78.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -0.66
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-294.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-294.54%
OCF growth 3YN/A
OCF growth 5YN/A